DAVID N GILL Insider Trading $MLNT MELINTA THERAPEUTICS, INC. /NEW/
Get free email notifications about insider trading for DAVID N GILL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID N GILL. DAVID N GILL is Senior Vice President and CFO in CTI MOLECULAR IMAGING INC ($CTMI) and in STRATA Skin Sciences, Inc. ($MELA) and Director in STRATA Skin Sciences, Inc. ($MELA) and Director in HISTOGENICS CORP ($HSGX) and Director in CEMPRA, INC. ($CEMP) and Director in Evolus, Inc. ($EOLS) and Chief Financial Officer in EndoChoice Holdings, Inc. ($GI) and President and CFO in EndoChoice Holdings, Inc. ($GI) and Director in Strongbridge Biopharma plc ($SBBP) and Director in Y-mAbs Therapeutics, Inc. ($YMAB).
DAVID N GILL in MELINTA THERAPEUTICS, INC. /NEW/
Trading Symbol: MLNTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID N GILL: Director
Holdings: 6,000 shares
Current Value: $18,000
Latest Transaction: Jun 12 2019
$MLNT Market Capitalization: $151.90M
$MLNT Previous Close: $3.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID N GILL in MELINTA THERAPEUTICS, INC. /NEW/
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTMI, GI, EOLS, MLNT, HSGX, MELA, SBBP, YMAB
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 12 2019 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 7.45 | 9,100 | 67,795 | 9,100 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 7.45 | 9,100 | 67,795 | 9,100 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
May 30 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Buy | P | 6.09 | 5,000 | 30,450 | 6,000 | 1,000 to 6 K (+500.00 %) |
Jan 05 2017 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 15,000 | |
Jan 04 2017 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Buy | P | 2.94 | 5,000 | 14,720 | 5,000 | 0 to 5 K |
Jan 05 2016 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Option Exercise | A | 31.13 | 15,000 | 466,950 | 15,000 |
Page: 1